Day 1 – Saturday, November 16

Ophthalmology Times welcomes ophthalmic professionals from around the world to New Orleans. Our four-day coverage of this year's meeting of the American Academy of Ophthalmology begins today and includes the latest research findings and clinical updates of interest to readers.
Enjoy the meeting!

REFRACTIVE SUBSPECIALTY DAY

Often forgotten in the buzz over corneal crosslinking (CXL) is that the procedure kills cells down to 300 µm deep, knocking out everything in its path—including microorganisms and keratocytes, said Theo Seiler, MD, PhD. » MORE

For patients with low to moderate hyperopia who may be risk-adverse for surgical correction, there is a low-cost, non-invasive, pain-free procedure of 2.5 seconds, said James J. Salz, MD. » MORE

Outcomes for three presbyopia-correcting IOLs—one accommodating and two multifocals—were similar, said Robert Edward Ang, MD. » MORE

INNOVATION AT OIS

The 5th annual Ophthalmology Innovation Summit (OIS) delivered in New Orleans this week. There was a record number of attendees—more than 800—a solid program covering a wide range of topics and issues, and there was plenty of dialogue outside the ballroom among the attendees from all segments of the ophthalmic market » MORE

RETINA SUBSPECIALTY DAY

Apoptosis may be the best characterized form of programmed cell death—but it isn't in isolation, said Joan W. Miller, MD. » MORE